AAPL332.35+1.01 (+0.30%) ▲|ABBV262.25-0.80 (-0.30%) ▼|ABT103.15+1.12 (+1.09%) ▲|ACN190.37-3.03 (-1.57%) ▼|ADBE250.91-6.85 (-2.66%) ▼|AMAT423.30+2.13 (+0.51%) ▲|AMD522.37+18.17 (+3.60%) ▲|AMGN376.85+1.20 (+0.32%) ▲|AMT179.31+1.60 (+0.90%) ▲|AMZN247.56-0.86 (-0.35%) ▼|AVGO342.41+3.14 (+0.92%) ▲|AXP317.11-7.32 (-2.26%) ▼|BA211.22+1.53 (+0.73%) ▲|BAC58.44-1.09 (-1.82%) ▼|BKNG173.13+1.81 (+1.06%) ▲|BLK1,047.95-10.71 (-1.01%) ▼|BMY64.15+0.42 (+0.66%) ▲|BNY155.09+0.42 (+0.27%) ▲|BRK-B520.53+3.77 (+0.73%) ▲|C135.17-1.00 (-0.73%) ▼|CAT791.36+7.82 (+1.00%) ▲|CL87.33+0.33 (+0.37%) ▲|CMCSA24.18-0.24 (-0.98%) ▼|COF206.80-0.05 (-0.02%) ▼|COP134.69-6.54 (-4.63%) ▼|COST901.54+0.19 (+0.02%) ▲|CRM250.90-4.76 (-1.86%) ▼|CSCO110.66+0.59 (+0.54%) ▲|CVS93.69-0.80 (-0.85%) ▼|CVX212.36-5.41 (-2.48%) ▼|DE674.73-9.31 (-1.36%) ▼|DHR208.10-1.27 (-0.60%) ▼|DIS107.86+1.44 (+1.35%) ▲|DUK118.65+0.88 (+0.75%) ▲|EMR148.64+1.64 (+1.12%) ▲|FDX302.91-5.35 (-1.74%) ▼|GD361.16+2.56 (+0.71%) ▲|GE317.05+10.00 (+3.26%) ▲|GEV931.29+48.48 (+5.49%) ▲|GILD148.93+2.63 (+1.79%) ▲|GM84.34-1.04 (-1.21%) ▼|GOOG342.27+0.84 (+0.25%) ▲|GOOGL345.68+0.70 (+0.20%) ▲|GS977.03+0.36 (+0.04%) ▲|HD307.77+2.29 (+0.75%) ▲|HON209.04+5.60 (+2.75%) ▲|IBM241.16-7.21 (-2.90%) ▼|INTC102.07+4.93 (+5.07%) ▲|INTU322.28-7.00 (-2.12%) ▼|ISRG386.36+9.20 (+2.44%) ▲|JNJ268.04+0.84 (+0.31%) ▲|JPM350.24-2.25 (-0.64%) ▼|KO88.43-0.28 (-0.32%) ▼|LIN465.08+2.12 (+0.46%) ▲|LLY1,144.80+8.69 (+0.76%) ▲|LMT538.64+5.18 (+0.97%) ▲|LOW196.36+1.75 (+0.90%) ▲|LRCX273.66+2.79 (+1.03%) ▲|MA570.34-2.93 (-0.51%) ▼|MCD250.76-2.02 (-0.80%) ▼|MDLZ62.60+0.50 (+0.81%) ▲|MDT94.37+0.62 (+0.66%) ▲|META677.37+7.13 (+1.06%) ▲|MMM162.64-2.03 (-1.23%) ▼|MO70.51+0.70 (+1.00%) ▲|MRK144.08+0.29 (+0.20%) ▲|MS206.86+0.58 (+0.28%) ▲|MSFT493.86-3.27 (-0.66%) ▼|MU928.86+1.26 (+0.14%) ▲|NEE81.24+0.17 (+0.20%) ▲|NFLX77.26-0.65 (-0.83%) ▼|NKE36.33+0.11 (+0.29%) ▲|NOW140.63-1.27 (-0.90%) ▼|NVDA216.18+4.01 (+1.89%) ▲|ORCL143.92+3.57 (+2.54%) ▲|PEP135.24-0.26 (-0.19%) ▼|PFE27.60+0.05 (+0.16%) ▲|PG147.89+1.22 (+0.83%) ▲|PLTR171.70-0.86 (-0.50%) ▼|PM194.01-0.11 (-0.05%) ▼|QCOM189.10+1.30 (+0.69%) ▲|RTX197.33+1.83 (+0.94%) ▲|SBUX97.95+1.37 (+1.42%) ▲|SCHW106.05-1.74 (-1.61%) ▼|SO86.66+0.71 (+0.82%) ▲|SPG204.50+0.40 (+0.20%) ▲|T26.36-0.37 (-1.37%) ▼|TMO643.94+2.55 (+0.40%) ▲|TMUS178.87-1.60 (-0.89%) ▼|TSLA361.86+5.28 (+1.48%) ▲|TXN265.23+1.80 (+0.68%) ▲|UBER71.31-0.13 (-0.18%) ▼|UNH379.32+3.39 (+0.90%) ▲|UNP285.46+1.47 (+0.52%) ▲|UPS99.79-2.56 (-2.50%) ▼|USB60.90-1.33 (-2.13%) ▼|V371.61-4.02 (-1.07%) ▼|VZ50.62-0.84 (-1.62%) ▼|WFC88.49-1.24 (-1.38%) ▼|WMT108.41+0.32 (+0.29%) ▲|XOM164.13-5.19 (-3.07%) ▼|AAPL332.35+1.01 (+0.30%) ▲|ABBV262.25-0.80 (-0.30%) ▼|ABT103.15+1.12 (+1.09%) ▲|ACN190.37-3.03 (-1.57%) ▼|ADBE250.91-6.85 (-2.66%) ▼|AMAT423.30+2.13 (+0.51%) ▲|AMD522.37+18.17 (+3.60%) ▲|AMGN376.85+1.20 (+0.32%) ▲|AMT179.31+1.60 (+0.90%) ▲|AMZN247.56-0.86 (-0.35%) ▼|AVGO342.41+3.14 (+0.92%) ▲|AXP317.11-7.32 (-2.26%) ▼|BA211.22+1.53 (+0.73%) ▲|BAC58.44-1.09 (-1.82%) ▼|BKNG173.13+1.81 (+1.06%) ▲|BLK1,047.95-10.71 (-1.01%) ▼|BMY64.15+0.42 (+0.66%) ▲|BNY155.09+0.42 (+0.27%) ▲|BRK-B520.53+3.77 (+0.73%) ▲|C135.17-1.00 (-0.73%) ▼|CAT791.36+7.82 (+1.00%) ▲|CL87.33+0.33 (+0.37%) ▲|CMCSA24.18-0.24 (-0.98%) ▼|COF206.80-0.05 (-0.02%) ▼|COP134.69-6.54 (-4.63%) ▼|COST901.54+0.19 (+0.02%) ▲|CRM250.90-4.76 (-1.86%) ▼|CSCO110.66+0.59 (+0.54%) ▲|CVS93.69-0.80 (-0.85%) ▼|CVX212.36-5.41 (-2.48%) ▼|DE674.73-9.31 (-1.36%) ▼|DHR208.10-1.27 (-0.60%) ▼|DIS107.86+1.44 (+1.35%) ▲|DUK118.65+0.88 (+0.75%) ▲|EMR148.64+1.64 (+1.12%) ▲|FDX302.91-5.35 (-1.74%) ▼|GD361.16+2.56 (+0.71%) ▲|GE317.05+10.00 (+3.26%) ▲|GEV931.29+48.48 (+5.49%) ▲|GILD148.93+2.63 (+1.79%) ▲|GM84.34-1.04 (-1.21%) ▼|GOOG342.27+0.84 (+0.25%) ▲|GOOGL345.68+0.70 (+0.20%) ▲|GS977.03+0.36 (+0.04%) ▲|HD307.77+2.29 (+0.75%) ▲|HON209.04+5.60 (+2.75%) ▲|IBM241.16-7.21 (-2.90%) ▼|INTC102.07+4.93 (+5.07%) ▲|INTU322.28-7.00 (-2.12%) ▼|ISRG386.36+9.20 (+2.44%) ▲|JNJ268.04+0.84 (+0.31%) ▲|JPM350.24-2.25 (-0.64%) ▼|KO88.43-0.28 (-0.32%) ▼|LIN465.08+2.12 (+0.46%) ▲|LLY1,144.80+8.69 (+0.76%) ▲|LMT538.64+5.18 (+0.97%) ▲|LOW196.36+1.75 (+0.90%) ▲|LRCX273.66+2.79 (+1.03%) ▲|MA570.34-2.93 (-0.51%) ▼|MCD250.76-2.02 (-0.80%) ▼|MDLZ62.60+0.50 (+0.81%) ▲|MDT94.37+0.62 (+0.66%) ▲|META677.37+7.13 (+1.06%) ▲|MMM162.64-2.03 (-1.23%) ▼|MO70.51+0.70 (+1.00%) ▲|MRK144.08+0.29 (+0.20%) ▲|MS206.86+0.58 (+0.28%) ▲|MSFT493.86-3.27 (-0.66%) ▼|MU928.86+1.26 (+0.14%) ▲|NEE81.24+0.17 (+0.20%) ▲|NFLX77.26-0.65 (-0.83%) ▼|NKE36.33+0.11 (+0.29%) ▲|NOW140.63-1.27 (-0.90%) ▼|NVDA216.18+4.01 (+1.89%) ▲|ORCL143.92+3.57 (+2.54%) ▲|PEP135.24-0.26 (-0.19%) ▼|PFE27.60+0.05 (+0.16%) ▲|PG147.89+1.22 (+0.83%) ▲|PLTR171.70-0.86 (-0.50%) ▼|PM194.01-0.11 (-0.05%) ▼|QCOM189.10+1.30 (+0.69%) ▲|RTX197.33+1.83 (+0.94%) ▲|SBUX97.95+1.37 (+1.42%) ▲|SCHW106.05-1.74 (-1.61%) ▼|SO86.66+0.71 (+0.82%) ▲|SPG204.50+0.40 (+0.20%) ▲|T26.36-0.37 (-1.37%) ▼|TMO643.94+2.55 (+0.40%) ▲|TMUS178.87-1.60 (-0.89%) ▼|TSLA361.86+5.28 (+1.48%) ▲|TXN265.23+1.80 (+0.68%) ▲|UBER71.31-0.13 (-0.18%) ▼|UNH379.32+3.39 (+0.90%) ▲|UNP285.46+1.47 (+0.52%) ▲|UPS99.79-2.56 (-2.50%) ▼|USB60.90-1.33 (-2.13%) ▼|V371.61-4.02 (-1.07%) ▼|VZ50.62-0.84 (-1.62%) ▼|WFC88.49-1.24 (-1.38%) ▼|WMT108.41+0.32 (+0.29%) ▲|XOM164.13-5.19 (-3.07%) ▼|
22.5 C
New York
Wednesday, September 16, 2026

Tag: well

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II...

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II...

Volvo Construction Equipment refocuses its presence in China – divests its shares in SDLG

GOTHENBURG, Sweden, June 24, 2025 /PRNewswire/ -- Volvo Construction Equipment (Volvo CE) has signed a contract to sell its ownership in China-based SDLG (Shandong...

Volvo Construction Equipment acquires Swecon

GOTHENBURG, Sweden, June 24, 2025 /PRNewswire/ -- Volvo Construction Equipment (Volvo CE) has come to an agreement with Lantmännen to acquire the Swecon's business operations...

Vitafoods Asia 2025 Is Ready to Connect Nutraceutical World This September

BANGKOK, June 24, 2025 /PRNewswire/ -- In an era where consumers are becoming more health-conscious and proactive about their well-being, the nutraceutical industry has...

Trinasolar and Universidad Politécnica de Madrid Strengthen Partnership with Inauguration of Demo Center

A new space to foster collaboration, innovation, and hands-on learning in solar energy — part of Trinasolar's growing global network of university-linked Demo Centers. MADRID,...

Trinasolar and Universidad Politécnica de Madrid Strengthen Partnership with Inauguration of Demo Center

A new space to foster collaboration, innovation, and hands-on learning in solar energy — part of Trinasolar's growing global network of university-linked Demo Centers. MADRID,...

Cielo Provides Update on Settlement Agreement, Shareholder Meeting and Webinar, and Units for Debt Transactions

Cielo Provides Update on Settlement Agreement, Shareholder Meeting and Webinar, and Units for Debt Transactions

Smart Automation Meets Medical Innovation: ICP DAS & ICP DAS-BMP at Manufacturing World Tokyo 2025

HSINCHU, June 24, 2025 /PRNewswire/ -- ICP DAS and its biomedical business unit, ICP DAS-BMP, are pleased to announce their participation in Manufacturing World...

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog...

Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...

Singapore to Host Inaugural International Chinese Film Awards This December

An annual international Chinese film award initiated by Singapore, the Golden Singa Awards is set to emerge as the region's foremost cultural and entertainment...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UnitedHealth, Bitfarms, and Reddit and Encourages Investors to Contact...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UnitedHealth Group Incorporated (NYSE: UNH), Bitfarms Ltd. (NASDAQ: BITF), and Reddit, Inc. (NYSE:RDDT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsWell